Green Synthesis of Terminalia ferdinandiana Exell-Mediated Silver Nanoparticles and Evaluation of Antibacterial Performance

利用Terminalia ferdinandiana Exell介导的绿色合成方法制备银纳米粒子并评价其抗菌性能

阅读:1

Abstract

This study uses a novel method in which extracts from different parts of a single plant are used to synthesize well-defined silver nanoparticles (AgNPs) to address the lack of capping agents in certain plant extracts. We focused on synthesizing AgNPs with enhanced biomedical activity using aqueous leaves and fruit extracts of Terminalia ferdinandiana Exell, a plant native to northern Australia that is known for its high phenolic content and associated health benefits. The impact of using parameters such as the Ag(+) ion-to-extract ratio and pH on AgNP synthesis was examined. The formation of AgNPs was confirmed using UV-visible spectrophotometry, transmission electron microscopy, and dynamic light scattering. The AgNPs synthesized at a pH of 8 and 1:25 Ag(+)/extract ratio exhibited the lowest particle size and polydispersity index. The AgNPs synthesized with leaf extract (AgKL) were monodisperse and exhibited a smaller hydrodynamic diameter (37 nm) compared to the fruit extract nanoparticles (AgKP), which were polydisperse and larger (147 nm). Phytochemicals in T. ferdinandiana aqueous leaf extract act as effective capping and stabilizing agents, enabling the synthesis of small-sized and homogenous AgNPs, which the fruit extract alone could not achieve. The in vitro bioactivity was evaluated using antioxidant and antibacterial assays and compared with the crude extract. Both the AgNPs and T. ferdinandiana extracts demonstrated strong 2,2 diphenyl-1-picrylhydrazyl radical scavenging activity. However, only AgKL showed excellent antibacterial activity against Gram-negative and Gram-positive bacteria based on minimum inhibitory and bactericidal results. Mixing 50% leaf extract with fruit extract resulted in well-stabilized NPs (AgKPL) with a hydrodynamic diameter of 33.4 nm and superior antibacterial properties. These results indicate that AgKL and AgKPL have significant potential for pharmaceutical and biomedical applications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。